Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000060

Director sold 1,666 shares at an average $65.13 ($108,510)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-21 Sale : show line 1 in the form −400 $64.25 $25,700 134,097 D
2021-07-21 Sale : show line 2 in the form −866 $65.24 $56,498 133,231 D
2021-07-21 Sale : show line 3 in the form −400 $65.78 $26,312 132,831 D
Open-market sales · 1,666 sh · avg $65.13 · $108,510
Loading xslF345X03/wf-form4_162707596730665.xml…